In agreement with other studies, our results revealed that ALT, AST, ALP, and γ-GTP activities were increased significantly in mice with TAA-induced liver fibrosis, whereas treatment with DPx reversed all abnormalities indicated by hepatic damage biomarkers. The gene discussed is GPT; the disease is Hepatic fibrosis.